Deadline: May 18, 2015
The Developmental Disabilities Translational Research Program supports researchers in developing treatments and improving outcomes for individuals with developmental disabilities, particularly Down syndrome and Fragile X syndrome (and FX associated disorders). The awards are made to the most highly innovative translational research projects that have the greatest potential of investigating rational and effective treatments and interventions for the particular condition being addressed. The program emphasizes interdisciplinary collaborative grant applications focused primarily on FXS and DS, but the program supports studies focused on other developmental disabilities under special circumstances..
Deadline: May 18, 2015
Irvington PostDoc Fellowship – due April 1, 2015
The Cancer Research Institute is currently accepting applications for its Postdoctoral Fellowship Program. The CRI Irvington Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in cancer immunology. The Institute is seeking hypothesis driven, mechanistic studies in both immunology and tumor immunology that seek to directly impact our understanding of the immune system’s role in cancer risk, tumor initiation, progression, metastasis, host response to tumors, and/or the treatment of cancer.
Deadline: April 1, 2015
Funding: $164,500 over three years
Contact: Lynne A. Harmer
Director of Grants Administration
Cancer Research Institute
National Institute of Food and Agriculture announces RFA
The U. S. Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) recently announced a Request for Applications (RFA) for the Agriculture and Food Research Initiative’s (AFRI) Childhood Obesity Prevention Challenge Area (COP) for fiscal year (FY) 2015. AFRI is NIFA’s primary competitive grant program that promotes knowledge in fundamental and applied sciences relevant to agriculture and food. The Obama Administration believes that obesity amongst children and adolescents (ages 2-19 years) is one of the top nutrition challenges facing the United States. Through this particular RFA, AFRI intends to make $6 million available for research, education, and extension programs that target this issue.
As such, the COP RFA seeks to combat the growing obesity challenge and reaffirms the Secretary of Agriculture and NIFA’s commitments “to preventive nutrition and physical activity strategies that will reduce obesity and related chronic diseases, and thereby lower healthcare costs.” 1 In pursuit of this long-term outcome, projects must seek to contribute to the achievement of the following goals:
- 1. “Generation of new knowledge about behavioral, social, cultural, and environmental factors that influence excessive weight gain by children and adolescents;
- 2. Development of effective behavioral, social, and environmental interventions to increase dietary intakes of fruits and vegetables; increase the variety of vegetables in the diet and decrease dietary intakes of foods high in solid fats and added sugars; increase the number of children who meet guidelines for television viewing and computer use; increase physical activity in children; and ultimately to decrease the proportion of children and adolescents who are overweight or obese;…
- 3. Expansion of interventions proven effective and assessment of their impact; and
- 4. An increase in the number of parents, caretakers, educators, practitioners, and researchers who receive the training and effectively model behaviors necessary to address the complex problem of childhood obesity prevention.”
Within this Challenge Area, AFRI will support: multi-function Integrated Research, Education, and Extension Projects; Food and Agricultural Science Enhancement (FASE) Grants; and conferences and/or workshops.” Specified program areas include:“Integrated Approaches to Prevent Childhood Obesity” and “Supplemental Nutrition Assistance Program and Expanded Food and Nutrition Education Program (SNAP & EFNEP): Nutrition Education and Obesity Prevention: Regional Centers of Excellence (RNECE).
Applications Due April 23, 2015
Total Funding and Award Sizes
Approximately $6 million is expected to be made available for awards under this program. Award sizes and periods vary by project type but must not exceed $1 million per year for five years.
Eligibility and Limitations: Eligible applicants include institutions of higher education and research organizations and institutions.
Additional Information on AFRI programs
The Charles H. Hood Foundation was incorporated in 1942 to improve the health and quality of life for children throughout New England. Today’s research projects encompass many disciplines that have contributed to discoveries in pediatric medicine while launching the careers of promising junior faculty. The intent of the Award is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of research funding. Research projects must be relevant to child health.
Online Application Deadline
Monday, March 30, 2015 at 12:00 Noon, U.S. Eastern Time
Funding Period and Award Amount
- July 1, 2015 – June 30, 2017
- Up to five $150,000 awards at $75,000 per year (inclusive of 10% institutional overhead)
Applicant, Project and Geographic Eligibility
- Investigators within five years of their first faculty appointment (inclusive of any independent research positions in a for-profit company)
- Research with relevance to child health
- Hypothesis-driven clinical, basic science, public health, health services research and epidemiology projects
- Nonprofit academic, medical or research institutions in New England
- United States citizenship or residency is not required
Please direct any questions to 617-695-9439 or GLockwood@hria.org.
SIG Pre-submission Process
The Shared Instrument Grant (SIG) program encourages applications from groups of NIH-sponsored investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000. Types of instruments supported include, but are not limited to: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters and biomedical imagers.
The office of the Associate Dean for Research, BUSM will facilitate an internal SIG pre-submission process to foster collaborative proposals and increase the success rate for the University. This pre-submission process requires that applicants fill out an online form designed inform Dr. Antman, BUSM Dean and BUMC Provost of your interest in applying for an S10 Shared Instrumentation Grant.
The proposals will be routed to the Core Advisory Committee, who will assist the Associate Dean for Research, BUSM and the Provost with evaluating scientific merit and ensuring that highly-rated applications receive the appropriate level of institutional support to make them most competitive.
This process will:
- Identify the necessary level of institutional support needed for a competitive application.
- Identify any potential space and renovation needs ahead of the application.
- Help obtain access to equipment, or equipment loans, in order to generate additional data to strengthen the application if needed.
- Alert other members of the research community who may be important additions to the users group, and ensure transparency of the SIG process.
- Ensure that we do not have competing applications for similar equipment.
This process is not intended to prevent submission of applications, but to recognize that when multiple applications are being submitted, it may not be possible to centrally support all of them at a competitive level from the Provost’s or the Deans’ resources, providing the opportunity to identify alternative sources of funding.
If you are considering submitting a SIG in 2015, please fill out the SIG pre-submission online form as soon as possible. The internal submission deadline university-wide is March 9
due March 9, 2015
Boston University School of Medicine and Boston Medical Center
Family Medicine Department’s 2015 Lynne Stevens Award
for Research or Practice Improvement Project on
Healthcare Responses to Violence Against Women
Lynne Stevens was Director of the Responding to Violence Against Women Program and an Assistant Professor at the Boston University School of Medicine, Department of Family Medicine. Stevens specialized in evaluation of the quality of care offered in medical settings to women impacted by partner and sexual violence. She died in 2009 at the age of 63.
The Award Program:
To continue Lynne’s work in this important area, the Department of Family Medicine, with the help of a generous donation, has established a grant to be awarded annually for the life of the fund, for research or practice improvement projects. The focus should be on the care received in the Boston University system by women who experience partner and sexual violence, including the hospitals, student health services and community health centers affiliated with Boston Medical Center. This is a University-wide program, so all faculty, staff, trainees and students of BU, BMC and affiliated community health centers and services are eligible to apply. Non-clinicians are encouraged to seek endorsement by practicing providers with a letter of support attesting to clinical relevance. Proposals will be reviewed by a Technical Advisory Committee (TAC) including experts in the field.
The Award Process:
Applicants are asked to submit a concept paper of no more than 3 pages to the committee via email by 10 AM Monday March 9, 2015 to Latia.Holmes@bmc.org, Carol.Mostow@bmc.org, and firstname.lastname@example.org (Karla Damus PhD MSPH MN RN FAAN). This concept paper should include the objectives of the study or project design, a description of how the results will be evaluated and used to improve clinical services, a timeline and budget. The project should be completed within a year, and the budget should not exceed $ 5,000. The TAC will review the concept papers, and ask for more detail from one or more applicants. The award will be announced in April and funded following any indicated IRB approval.
For more information:
Contact Joanne.Wilkinson@bmc.org Joanne Wilkinson MD, M.Sc., Director of Research, Department of Family Medicine, Boston University School of Medicine and Boston Medical Center or Carol.Mostow@bmc.org Carol Mostow LICSW, Chair of the Lynne Stevens Memorial Committee
Congressionally Directed Medical Research Programs Military Operational Medicine Research Program/Joint Program Committee-5 Alcohol and Substance Abuse Research Program Consortium Award Funding Opportunity Number: W81XWH-14-ASARP-CA
Applications to the Fiscal Year 2014 (FY14) Alcohol and Substance Abuse Research Program (ASARP) are being solicited for the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate, by the U.S. Army Medical Research Acquisition Activity (USAMRAA). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the DHA RDA Directorate manages and executes the Defense Health Program (DHP) Research, Development, Test, and Evaluation appropriation. The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) operates in partnership with the Joint Program Committee 5/Military Operational Medicine Research Program (JPC-5/MOMRP) to provide oversight and execution management for the ASARP.
The goal of the ASARP is to identify and develop new medications to improve treatment outcomes for alcohol and substance use disorders (ASUD), especially as related to traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). The program encourages the use of collaborative, multidisciplinary approaches to accelerate the translation of basic research into clinical trial studies.
The program’s approach is to organize multidisciplinary, team-based translational research efforts to:
1. Identify promising compounds;
2. Conduct proof-of-principle basic research to determine which compounds are most appropriate for human research trials;
3. Conduct human proof-of-principle trials with promising compounds. This approach should accelerate the translation of contemporary basic science knowledge into enhanced clinical pharmacological treatment protocols for ASUD, including a regulatory strategy for U.S. Food and Drug Administration (FDA) compliance.
- Consortium Award – Letter of intent deadline February 26, 2015, full application is due March 5, 2015
- Must be an independent investigator at or above the level of Assistant Professor (or equivalent).
- Intended to support an ASUD-focused Consortium aimed at developing new medications to improve treatment outcomes, especially as related to traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD)
- Objectives: (1) Identify promising compounds; (2) Conduct proof-of-principle basic research to determine which compounds are most appropriate for human research trials; Conduct human proof-of-principle trials with promising compounds. This approach should accelerate the translation of contemporary basic science knowledge into enhanced clinical pharmacological treatment protocols for ASUD, including a regulatory strategy for U.S. Food and Drug Administration (FDA) compliance
- The maximum period of performance is 5 years.
- The maximum allowable total costs for the entire period of performance are $10.8M of which only $3.6M is currently available.
- The applicant may request two options up to $3.6M in total costs each, to fund additional basic research projects, clinical trials, associated Management Core costs, and Consortium activities.
All applications must conform to the final Program Announcements and General Application Instructions that are available for electronic downloading from the Grants.gov website. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government’s single-entry portal, Grants.gov. Requests for email notification of the Program Announcements release may be sent to help@eBRAP.org. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
Point of Contact:
Bookmark the CDMRP website:
Follow CDMRP on Twitter at:
View CDMRP research results on YouTube:
The Massachusetts Life Sciences Center’s Cooperative Research Matching Grant Program is providing funding of up to $250,000 per year for two years, for projects that advance “industry-academic research collaborations, support translational research, and accelerate the commercialization of promising products and services.” The industry partner is required to provide 1:1 matching funds.
Applications are due February 13th. http://www.masslifesciences.com/programs/crmg/
Any researchers interested in this opportunity should contact:
Director of Foundation Relations
Boston University School of Medicine
72 E. Concord Street, Suite L219
Boston, MA 02118
Pfizer’s Centers for Therapeutic Innovation (CTI) has announced a call for proposals for biotherapeutic targets. Areas of Interest include:
- Tissue remodeling
- Cancer Immunology
- Rare or genetic diseases
- Cardiovascular and metabolic diseases
Deadline: A 2-3 page pre-proposal is due 2/13/15.
The budget varies per project ranging $150,000-250,000 per year sponsored research.
For more details, please see the attached flyer and guidelines below.
Collaboration among Leading Lupus Organizations Continues with
Third Lupus Insight Prize – due March 19, 2015
The Lupus Research Institute (LRI) is proud to join once again with the Alliance for Lupus Research and Lupus Foundation of America to encourage scientific advances in lupus research. Now in its third year, the Lupus Insight Prize recognizes a major novel insight and/or discovery with the promise of changing thinking about lupus as well as a high likelihood of generating significant advances in diagnosis and treatment of the disease.
The Lupus Insight Prize recipient will be awarded $200,000 to be used for research dedicated to advancing understanding of the genetic, environmental, molecular, immunologic or cellular aspects of lupus and/or its treatment. The Prize must be utilized within three years from the date awarded.
LRI Scientific Advisory Board Member and Editor-in-Chief of Arthritis Research and Therapy Peter Lipsky, M.D. noted, “Lupus is a complex disease that requires out-of-the-box thinking to increase understanding and further our ability to treat persons with this disease effectively. Quantum leaps in understanding lupus will come from innovative discoveries by outstanding scientists. The Lupus Insight Prize will recognize those novel discoveries.”
The full application must be submitted by the Nominator and the Candidate electronically by March 19, 2015 at 5 p.m. ET. All applications will be reviewed by members of an independent Selection Committee comprised of representatives of the three funding lupus organizations. Instructions on how to submit a nomination for the Lupus Insight Prize and the complete guidelines are available at www.LupusInsightPrize.org. The 2015 Prize will be awarded by the three organizations at the Federation of Clinical Immunology Societies (FOCIS) annual meeting in San Diego this June.